HERON ELAINE J Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$7.44M

Insider Activity of HERON ELAINE J

According to the SEC Form 4 filings, HERON ELAINE J, being in a position of

  1. director at Palvella Therapeutics, Inc.,
    оver the last 12 months, has bought 2400 shares for $300,000, and sold 0 shares,
    over all time since 2026-02-27, has bought 2400 shares for $300,000, and sold 0 shares.

Biography of HERON ELAINE J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $300,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-02-27PurchasePalvella Therapeutics, Inc.
PVLA
director
2,400
0.0188%
$125.00$300,000-2.36%
2018-09-05SaleBioMarin Pharmaceutical Inc.
BMRN
director
2,000
0.0011%
$96.94$193,870-6.15%
2017-12-14SaleBioMarin Pharmaceutical Inc.
BMRN
director
1,600
0.0009%
$88.89$142,232+4.3%
2012-11-12SaleBioMarin Pharmaceutical Inc.
BMRN
director
1,875
0.0016%
$48.33$90,612+28.79%
2012-11-09SaleBioMarin Pharmaceutical Inc.
BMRN
director
30,000
0.0039%
$7.46$223,800+28.47%
2012-11-07SaleBioMarin Pharmaceutical Inc.
BMRN
director
105,000
0.0872%
$46.44$4.88M+32.8%
2008-03-06SaleBioMarin Pharmaceutical Inc.
BMRN
director
30,000
0.0314%
$38.04$1.14M-26.52%
2008-03-03SaleBioMarin Pharmaceutical Inc.
BMRN
director
20,000
0.0208%
$38.47$769,400-27.56%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.